This inventor holds 13 USPTO granted patents and 8 published patent applications, plus 4 CIPO patents and 7 EPO patents. Top assignees: Universitè Catholique De Louvain, Promethera Biosciences S.a./n.v., Promethera Therapeutics Sa. Active years: 2014-2023.
Company Filing History:
10 out of 100 
2 out of 2 
1 out of 1 Years Active: 2014-2023
Title: The Innovative Journey of Etienne Sokal
Introduction
Etienne Sokal is a prominent inventor based in Hoeilaart, Belgium, known for his significant contributions to the field of regenerative medicine. With an impressive portfolio of 13 patents, Sokal's work focuses on leveraging human liver stem cells to develop innovative treatments for liver disorders.
Latest Patents
Among Sokal's latest innovations are two groundbreaking patents. The first, titled "Conditioned medium from human adult liver stem cells and its use in the treatment of liver disorders," describes a novel cell-free composition derived from culturing adult-derived human liver stem/progenitor cells (ADHLSC). This conditioned medium (ADHLSC-CM) exhibits anti-fibrotic properties and is envisaged for use in various therapeutic applications, including the treatment of organ injuries, failures, and related conditions.
The second patent, "Method for producing adult liver progenitor cells," presents a novel characterization of adult liver progenitor cells, known as H2Stem Cells. This patent outlines methods to produce these cells in adherent forms and three-dimensional clusters. These cells are particularly useful for treating liver diseases or assessing the efficacy and safety of various compounds.
Career Highlights
Throughout his career, Etienne Sokal has contributed to academic institutions, most notably the Université Catholique de Louvain, where he has been involved in pioneering research projects that leverage stem cell technology. His innovative approach has further enhanced the understanding and treatment of liver-related ailments.
Collaborations
Sokal has actively collaborated with notable colleagues such as Mustapha Najimi and Sarah Snykers. These collaborations have fostered a research environment conducive to significant breakthroughs in the realm of liver stem cell applications and treatments.
Conclusion
Etienne Sokal's inventive spirit and dedication to medical advancements position him as a vital figure in the field of regenerative medicine. His patents not only hold promise for treating liver disorders but also pave the way for future innovations in the use of stem cells in therapeutic applications. As his journey continues, the medical community watches with great anticipation.